Extramural Discovery Science Accelerator Award
Extramural Discovery Science Accelerator Award supports cancer researchers with experiments to validate and de-risk technologies from ongoing projects, helping move them toward commercialization.
Browse similar grants
Funder: American Cancer Society
Due Dates: Rolling (Applications) | June 1, 2027 (July review cutoff)
Funding Amounts: Up to $75,000 total costs for one year; indirect costs are not allowed
Summary: Supports experiments that validate and de-risk technologies from ongoing cancer research projects for commercialization.
Key Information: Applicants must be independent investigators with full-time faculty appointments or equivalent at eligible US nonprofit institutions.
Description
The American Cancer Society’s Extramural Discovery Science (EDS) Accelerator Award supports commercially driven experiments needed to move an ongoing cancer research project toward commercialization. It targets work that does not easily fit traditional grant funding mechanisms, rather than new projects or new directions within existing projects. The principal investigator must have a plan to license the technology to an established company or a start-up if the experiments succeed.
Supported work may include dosing, toxicity, or efficacy testing; testing biopsies or other patient samples to correlate clinical outcomes; and technologies for healthcare delivery. Awardees also join an entrepreneurial collaborative learning community focused on technology commercialization, with access to educational programming developed by the ACS BrightEdge team and to the team itself.
